Insider Transactions in Q4 2024 at Aprea Therapeutics, Inc. (APRE)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 23
2024
|
Oren Gilad President/CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.15%
|
$1,500
$3.92 P/Share
|
|
Oct 18
2024
|
Marc Duey Director |
SELL
Open market or private sale
|
Direct |
6,462
-2.69%
|
$25,848
$4.58 P/Share
|
|
Oct 16
2024
|
Marc Duey Director |
BUY
Open market or private purchase
|
Direct |
30,000
+11.11%
|
$120,000
$4.39 P/Share
|
|
Oct 15
2024
|
Oren Gilad President/CEO |
BUY
Open market or private purchase
|
Direct |
250
+0.08%
|
$500
$2.9 P/Share
|
|
Oct 14
2024
|
Marc Duey Director |
BUY
Open market or private purchase
|
Direct |
190
+0.09%
|
$380
$2.58 P/Share
|
|
Oct 14
2024
|
Oren Gilad President/CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.3%
|
$2,000
$2.59 P/Share
|
|
Oct 11
2024
|
John P. Hamill SrVP/CFO/Prin Fin & Acct Ofcr |
BUY
Open market or private purchase
|
Direct |
50
+0.26%
|
$100
$2.46 P/Share
|
|
Oct 11
2024
|
Bernd R. Seizinger Director |
BUY
Open market or private purchase
|
Direct |
10,000
+18.27%
|
$20,000
$2.68 P/Share
|
|
Oct 10
2024
|
John P. Hamill SrVP/CFO/Prin Fin & Acct Ofcr |
BUY
Open market or private purchase
|
Direct |
450
+2.28%
|
$900
$2.61 P/Share
|
|
Oct 10
2024
|
Oren Gilad President/CEO |
BUY
Open market or private purchase
|
Direct |
150
+0.05%
|
$300
$2.54 P/Share
|